Prestige Consumer Healthcare Inc. (PBH)
Health Care / Pharmaceuticals
S&P SmallCap 600$46.51
Scores poorly across most models. Proceed with caution.
Weak
Score based on 5 of 5 models — high confidence
Is Prestige Consumer Healthcare Inc. a Good Investment in 2026?
Prestige Consumer Healthcare Inc. (PBH) scores 3.7 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Greenblatt Magic Formula model rates Prestige Consumer Healthcare Inc. as Strong (Top 25% (rank 13%)). The Lynch model is the least favorable, rating it Neutral. Prestige Consumer Healthcare Inc. ranks #916 out of 1125 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Trades at 12x earnings — near sector median of 25x.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Neutral
Business quality & competitive moat
Graham
Neutral
21% below fair value
Lynch
Neutral
PEG 0.9 · Fast Grower
Greenblatt
Strong
Top 25% (rank 13%)
Frequently Asked Questions
Is Prestige Consumer Healthcare Inc. (PBH) a good investment?
What is Prestige Consumer Healthcare Inc.'s Piotroski F-Score?
Is PBH overvalued or undervalued?
How does PBH compare to other Health Care stocks?
What do investment models say about PBH?
Similar Stocks
Compare PBH with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer